Temasek Holdings’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Temasek Holdings’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-566,650	Closed	-$703K	–	143
2024 Q3	$703K	Hold	566,650	–	–	﹤0.01%	119
2024 Q2	$946K	Hold	566,650	–	–	﹤0.01%	88
2024 Q1	$1.05M	Hold	566,650	–	–	0.01%	99
2023 Q4	$1.08M	Hold	566,650	–	–	0.01%	95
2023 Q3	$748K	Hold	566,650	–	–	﹤0.01%	78
2023 Q2	$1.69M	Hold	566,650	–	–	0.01%	63
2023 Q1	$1.96M	Hold	566,650	–	–	0.01%	62
2022 Q4	$2.37M	Hold	566,650	–	–	0.01%	62
2022 Q3	$2.27M	Hold	566,650	–	–	0.01%	70
2022 Q2	$6.4M	Hold	566,650	–	–	0.04%	74
2022 Q1	$9.2M	Hold	566,650	–	–	0.04%	82
2021 Q4	$26.9M	Hold	566,650	–	–	0.1%	65
2021 Q3	$41.1M	Sell	566,650 -39,420	-7%	-$2.85M	0.14%	59
2021 Q2	$50.9M	Buy	+606,070	New	+$40M	0.17%	55

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

EPL

EDBI Pte Ltd Singapore $94.4M AUM 32.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Temasek Holdings's NBP Position: Q4 2024 in Review

Temasek Holdings sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2024, closing a stake of 566,650 shares — an estimated $703K sold.

Temasek Holdings first reported a position in NBP in Q2 2021 and held it in 14 quarters. The position peaked at $50.9M in Q2 2021. 28 funds tracked by Wall St. Rank hold NBP as of Q4 2024.

Temasek Holdings reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2024 after selling out during the quarter.
Temasek Holdings sold 566,650 NovaBridge Biosciences American Depositary Shares shares in Q4 2024, an estimated $703K.
Temasek Holdings first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 14 quarters.
Temasek Holdings's NovaBridge Biosciences American Depositary Shares position peaked at $50.9M in Q2 2021.
28 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2024.

Based on Temasek Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.